Evidence map›Paper›PMID 39435420›Full record

ArticleCytotechnology2024

Conditioned media from human adipose tissue-derived mesenchymal stem cells: potential effect on peripheral blood mononuclear cells in co-culture with HeLa cell line.

Maryam Dorfaki, Fatemeh Faraji, Mona Roozbehani, Fahimeh Lavi Arab, Majid Khoshmirsafa, Reza Falak, Mahdi Ghatrehsamani

Abstract read
In one paragraph

Article in Cytotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maryam DorfakiDepartment of Microbiology and Immunology, School of Medicine, Shahrekord University of Medicine Sciences, Kashani Blvd, 88155137 Shahrekord, Iran.
Fatemeh FarajiAntimicrobial Resistance Research Center, Institute of Immunology and Infection Diseases, Iran University of Medicine Sciences, Tehran, Iran.
Mona RoozbehaniVaccine Research Center, Iran University of Medical Sciences, Tehran, Iran.
Fahimeh Lavi ArabDepartment of Immunology, School of Medicine, Mashhad University of Medicine Sciences, Mashhad, Iran.
Majid KhoshmirsafaImmunology Research Center, Institute of Immunology and Infection Diseases, Iran University of Medicine Sciences, Tehran, Iran.
Reza FalakImmunology Research Center, Institute of Immunology and Infection Diseases, Iran University of Medicine Sciences, Tehran, Iran.
Mahdi GhatrehsamaniDepartment of Microbiology and Immunology, School of Medicine, Shahrekord University of Medicine Sciences, Kashani Blvd, 88155137 Shahrekord, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of mesenchymal stem cells (MSCs) for the treatment of various diseases is being investigated, however, their use in cervical cancer has not been well-studied. Here, we examined the impact of collected MSC-conditioned medium (CM) on 1 to 5 days on apoptosis, proliferation, and cytokine production of peripheral blood mononuclear cells (PBMCs) when co-cultured alongside the HeLa cell line for 24, 48, and 72 h by CFSE assay, flow cytometry, and real-time PCR, respectively. We found that CMs collected on the third day of MSCs culture significantly increased the proliferation of PBMCs and decreased the proliferation of HeLa cells after 48 h. CMs showed no significant effects on cell death, whereas it significantly increased the apoptosis of HeLa cells. Real-time PCR analysis showed that the presence of CM collected on the third day of MSCs culture caused a significant increase in the gene expression of IL2, IFN-γ, and TGF-β in PBMCs after 48 h co-culture with HeLa cells. The data mentioned earlier demonstrate that MSC-CM can induce the growth and endurance of PBMCs while concurrently culturing HeLa cells. This observation indicates their promising potential as immunomodulatory therapies for cervical cancer cells. Nevertheless, additional investigation is imperative to comprehensively comprehend the fundamental mechanisms and refine therapeutic strategies involving PBMCs and mesenchymal stem cells.

Indexed as

ApoptosisCancerHeLaMSC (mesenchymal stem cell)PBMC

Identifiers

PMID39435420
PMCPMC11490470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.